SEOM clinical guideline in nasopharynx cancer (2017)
- PMID: 29098554
- PMCID: PMC5785612
- DOI: 10.1007/s12094-017-1777-0
SEOM clinical guideline in nasopharynx cancer (2017)
Abstract
Nasopharyngeal carcinoma (NPC) is distinct from other cancers of the head and neck in biology, epidemiology, histology, natural history, and response to treatment. Radiation therapy is an essential component of curative-intent of non-disseminated disease and the association of chemotherapy improves the rates of survival. In the case of metastatic disease stages, treatment requires platinum/gemcitabine-based chemotherapy and patients may achieve a long survival time.
Keywords: Locally-advanced disease; Nasopharynx cancer; Recurrent/metastatic disease; Treatment guidelines.
Conflict of interest statement
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
This article does not contain any studies with human participants performed by any of the authors.
References
-
- Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available from: http://globocan.iarc.fr. Accessed on day/month/year.
-
- Pathology and genetics of head and neck tumors. In: Barnes L, Eveson JW, Reichart P, Sidransky D, editors. World Health Organization classification of tumours. IARC Press, Lyon 2005.
-
- NCCN Clinical Practice Guidelines in Oncology (Head and Neck Cancers) Version 1.2017—February 6, 2017.
-
- Kubrak C, Olson K, Jha N, Jensen L, McCargar L, Seikaly H, et al. Nutrition impact symptoms: Key determinants of reduced dietary intake, weight loss, and reduced functional capacity of patients with head and neck cancer before treatment. Head Neck. 2010;32:290–300. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
